Ticker brief
LABD
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
32
authors 14d
4
crowd 14d
+0.6σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-16 · now +0.37 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Biotech2k1 | A | +1.11 | 27 | +0.54 |
| @MrStockLockPro1 | C | -2.14 | 3 | +0.45 |
| @Optimalinvestme | C | -2.28 | 1 | -0.40 |
| @MikeJTrades | C | · | 1 | +0.30 |
Recent signals30of 32 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @MikeJTrades | +0.30 | Lists quantified premarket and intraday performance for leading gainers. | · | tweet ↗ |
| 2026-10-16 | @Biotech2k1 | +0.20 | The author is watching for a biotech rally before potentially adding a LABD hedge. | · | tweet ↗ |
| 2026-10-16 | @Biotech2k1 | +0.60 | Use a biotech rally today as an opportunity to add a LABD hedge. — The author put LABD back on the list and plans to hedge after a biotech pop. | · | tweet ↗ |
| 2026-10-12 | @Biotech2k1 | +0.40 | Reports selling LABD for another gain and remains dismissive of MRNA. | · | tweet ↗ |
| 2026-10-10 | @MrStockLockPro1 | +0.20 | Weekly recap lists completed entry-to-exit performance, a hit target and one untriggered trade. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.40 | Discloses using LABD to express the position discussed in the thread. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.75 | Long LABD to profit from an expected MRNA reversal toward $50. — Discloses LABD purchase as a bearish MRNA expression and predicts MRNA will return to $50. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.80 | Bought half a LABD position at $7.50; bids the other half at $7 while long value biotech. — Explicit staged LABD entry hedges long positions in selected value-biotech names. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.65 | Standing bid to buy LABD at $7.50 today. — Explicitly states a current limit bid and entry price for LABD. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.65 | Waiting for a LABD bid to trigger ahead of a possible setup next week. — Active LABD bid plus a bullish trendline-pullback setup supplies concrete entry intent. | · | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.60 | Add a LABD hedge into a big biotech rally. — Author states a concrete plan to add a LABD hedge into an expected biotech pop. | · | tweet ↗ |
| 2026-10-08 | @MrStockLockPro1 | +0.80 | Promotional recap says LABD broke the prior $7.60 entry and reached $8.78, clearing targets. | · | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | +0.70 | Buy LABD into tomorrow's biotech short-covering rally. — Author explicitly plans to buy LABD during an expected biotech rally. | · | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | +0.65 | Would buy LABD here into the biotech pop. — Conditional language still clearly states immediate buy intent for LABD. | · | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | +0.65 | Buy LABD into a dead-cat bounce, with upside toward 9.45. — States prospective buy intent and a chart-derived upside target. | · | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | -0.35 | Abandon the planned LABD hedge because it has fallen too far. — Author explicitly cancels a prospective LABD hedge. | · | tweet ↗ |
| 2026-10-07 | @Optimalinvestme | -0.40 | Author describes using XBI direction to choose leveraged bullish LABU or bearish LABD for biotech day trading. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | +0.55 | Buying IDYA and waiting to establish a LABD position. — Discloses an IDYA buy and forward intent to enter LABD. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | -0.15 | Says attempts to bid LABD coincide with biotech bottoms, making the short difficult. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | +0.70 | Buy LABD if meme biotech rallies enough, using SMMT gains within a long/short strategy. — Plans a conditional biotech hedge while holding realizable gains in SMMT. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | +0.35 | Watching LABD as a potential hedge while existing trades have GTC sale orders. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | +0.70 | Sell one biotech holding and buy LABD if the sector mounts a strong rally. — Plans a conditional rotation from a biotech stock into inverse-biotech exposure. | · | tweet ↗ |
| 2026-10-06 | @MrStockLockPro1 | +0.35 | LABD reached $8.16 and closed at $7.97. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.50 | Discloses over 41% biotech exposure while seeking a LABD hedge after a large XBI rally. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.60 | Seek another opportunity to buy LABD and short top meme biotech stocks. — Expresses forward intent to obtain inverse-biotech exposure on another rally. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.40 | Returns LABD to the watch list after buying an unspecified dip and updating sell orders. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.80 | Plans to buy LABD to short hype-driven XBI holdings. — Explicit forward plan to use inverse-biotech ETF LABD against overhyped XBI constituents. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.85 | Will buy LABD at today's open. — Explicit imminent entry into LABD to short expensive biotech stocks indirectly. | · | tweet ↗ |
| 2026-10-06 | @Biotech2k1 | +0.80 | Will establish LABD today as the short-bubble leg of a biotech strategy. — Explicit planned LABD entry paired with long-value and short-momentum biotech positioning. | · | tweet ↗ |
| 2026-10-05 | @Biotech2k1 | +0.80 | Trying to buy LABD while holding deep-value biotech longs. — Explicit ongoing bid for LABD as the short leg of a long-value/short-momentum strategy. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.